Home › Funds › Principal Global Investors › GPCR
Principal Global Investors position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.75M sh
Reported value held$94.07M
Portfolio Weight0.05%
First reportedQ2 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 165.24K | $6.49M | New |
| Q4 2024 | 791.13K | $21.46M | New |
| Q1 2025 | 756.71K | $13.10M | Reduce |
| Q2 2025 | 853.20K | $17.70M | Add |
| Q3 2025 | 787.48K | $22.05M | Reduce |
| Q4 2025 | 1.28M | $89.32M | Add |
| Q1 2026 | 1.75M | $84.53M | Add |
| Q2 2026 | 1.75M | $94.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GPCR
- Fidelity Management & Research (FMR) 7.81M sh · $419.18M · Q2 2026
- Wellington Management Group 7.38M sh · $396.05M · Q2 2026
- Morgan Stanley 2.81M sh · $150.63M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- Franklin Resources 578.84K sh · $31.07M · Q2 2026
- Bank of America Corp 563.42K sh · $30.24M · Q2 2026
- BlackRock Inc 511.15K sh · $27.43M · Q2 2026
- Goldman Sachs Group 387.79K sh · $20.81M · Q2 2026
- UBS Group AG 378.99K sh · $20.34M · Q2 2026
- Deutsche Bank AG 331.87K sh · $17.81M · Q2 2026
- Marshall Wace 267.59K sh · $14.36M · Q2 2026